treatment-resistant depression - Search News

US FDA approves new nasal spray for depression treatment

Popular Science · 5h

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

Hosted on MSN · 1d

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

New York Post · 19h

J&J’s ketamine-derived nasal spray approved by FDA to treat depression

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression.

Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases

J&J announced the FDA’s supplemental approval Tuesday. Previously, Spravato was approved as an add-on therapy for ...

Psychology Today4d

New Strategies for Treatment-Resistant Depression

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

A Nasal Spray For Depression? FDA Gives Its Approval

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results